0001140361-23-013063.txt : 20230322 0001140361-23-013063.hdr.sgml : 20230322 20230322161340 ACCESSION NUMBER: 0001140361-23-013063 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230320 FILED AS OF DATE: 20230322 DATE AS OF CHANGE: 20230322 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ehrnrooth Eva CENTRAL INDEX KEY: 0001891333 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41008 FILM NUMBER: 23753096 MAIL ADDRESS: STREET 1: 1209 ORANGE STREET CITY: WILMINGTON STATE: DE ZIP: 19801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IO Biotech, Inc. CENTRAL INDEX KEY: 0001865494 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870909276 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: OLE MAALOES VEH 3 CITY: COPENHAGEN STATE: G7 ZIP: 2200 BUSINESS PHONE: 4570702980 MAIL ADDRESS: STREET 1: OLE MAALOES VEH 3 CITY: COPENHAGEN STATE: G7 ZIP: 2200 4 1 form4.xml X0407 4 2023-03-20 0001865494 IO Biotech, Inc. IOBT 0001891333 Ehrnrooth Eva C/O IO BIOTECH, INC. OLE MAALOES VEH 3 COPENHAGEN G7 2200 DENMARK true Chief Medical Officer false Stock Option (Right to Buy) 1.98 2023-03-20 4 A 0 120000 0 A 2033-03-20 Common Stock 120000 120000 D One-fourth of these options vest on March 20, 2024, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 50% acceleration upon a change of control and subject to 100% acceleration upon termination of service by the Issuer without cause within 24 months of a change of control. /s/ Brian Burkavage, Attorney-in-Fact for Eva Ehrnrooth 2023-03-22